Med. praxi 2013; 10(11-12): 369-371

Adherence and how to influence it

doc.MUDr.Michal Vrablík, Ph.D.
Centrum preventivní kardiologie, 3. interní klinika 1. LF UK a VFN v Praze

Adherence to treatment has been paid a great deal of attention in recent years. We already know that cooperation with patients significantly

affects treatment outcome and non-adherent behaviour borne in mind more often. There are a number of ways how to influence

adherence. The main role in this regard is played by the physician and other health care workers. Repeated, systematic education with

the use of methods improving its efficacy (written documentation, use of illustrative materials and models) increases the understanding

of the disease as well as the therapeutic intervention by the patient, which is an essential precondition for improved cooperation. The choice

of rational pharmacological treatment with an emphasis not only on efficacy but also good tolerance is undoubtedly an important element

in the strategy towards improved adherence. The amount of time devoted to this issue will certainly pay off in the form of better treatment

outcomes and, ultimately, in improved prognosis of the patients.

Keywords: adherence, cardiovascular risk, arterial hypertension, dyslipidaemia, education

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrablík M. Adherence and how to influence it. Med. praxi. 2013;10(11-12):369-371.
Download citation

References

  1. International Society for Pharmacoeconomics & Outcomes Research. http://www.ispor.org/sigs/mcp_accomplishments.asp.
  2. Ceral J, Habrdová V, Voříšek V, et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011; 34(1): 87-90. Go to original source... Go to PubMed...
  3. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002; 288(4): 462-467. Go to original source... Go to PubMed...
  4. Bautista LE. Predictors of Persistence With Antihypertensive Therapy: Results From the NHANES. Am J Hypertens 2008; 21: 183-188. Go to original source... Go to PubMed...
  5. Nelson MR, Reid CM, Ryan P, et al. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust. 2006; 185(9): 487-489. Go to original source... Go to PubMed...
  6. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557): 15. Go to original source... Go to PubMed...
  7. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5): 348-354. Go to original source... Go to PubMed...
  8. Makani H, Bangalore S, Romero J, et al. Effect of renin-angiotensin systém blockade on calcium channel blocker-associated peripheral edema. The American Journal of Medicine 2011; 124: 128-135. Go to original source... Go to PubMed...
  9. Bangalore S, Kamalakkannan G, Parkar S. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007; 120(8): 713-719. Go to original source... Go to PubMed...
  10. Filipovský J, Widimský J Jr, Ceral J, et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Hypertenze KV prevence 2012; 1: 1-16.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.